Lipkus IM, Peters E., Kimmick G., Liotcheva V., Marcom P.Breast cancer patients’ treatment expectations after exposure to the decision aid program Adjuvant Online: the influence of numeracy. Med Decis Making. 2010;30:464-73.
2.
Tzeng JP, Mayer D., Richman AR, et al. Women’s experiences with genomic testing for breast cancer recurrence risk. Cancer. 2010;116:1992-2000.
3.
Kattan MW, Potters L., Blasko JC, et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology. 2001;58:393-9.
4.
Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19:980-91.
5.
Belkora JK, Rugo HS, Moore DH, et al. Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis. BMC Cancer. 2009;9:127.
6.
Hutton DW, Belkora JK, Shachter RD, et al. Are patients getting the ‘‘gist’’ in risk communication? Patient understanding of prognosis in breast cancer treatment . J Cancer Educ. 2009;24:194-9.
7.
Zikmund-Fisher BJ, Fagerlin A., Ubel PAImproving understanding of adjuvant therapy options by using simpler risk graphics. Cancer. 2008;113:3382-90.
8.
Vos MS, de Haes JCDenial in cancer patients: an explorative review. Psychooncology . 2007;16:12-25.
